Lifeward Ltd.
0.6590-0.00 (-0.3%)
Oct 29, 4:00:02 PM EDT · NasdaqCM · LFWD · USD
Key Stats
Market Cap
10.35MP/E (TTM)
-Basic EPS (TTM)
-3.15Dividend Yield
0%Recent Filings
8-K
Lifeward's Q3 prelims show slim margin
Lifeward Ltd. disclosed preliminary Q3 2025 revenue of approximately $6.2 million, edging out operating expenses of $5.8 million to $5.9 million. Cash and equivalents stood at $2.0 million as of September 30. These figures, subject to final review, signal a slim operating margin amid tight liquidity. Final results await the 10-Q filing.
8-K
Lifeward Q2 revenue dips, cash improves
Lifeward Ltd. reported Q2 2025 revenue of $5.7 million, down 15% from $6.7 million in Q2 2024 but up 14% from Q1 2025, amid record ReWalk placements for Medicare beneficiaries and over 130 qualified U.S. leads. Cash burn improved to $3.9 million from $5.6 million year-over-year, fueled by efficiencies and in-house manufacturing shift, while a $2.8 million goodwill impairment widened net loss to $6.6 million. New CEO Mark Grant and CFO Almog Adar aim to drive growth. Guidance targets $24–$26 million revenue and $12–$14 million non-GAAP net loss for 2025.
10-Q
Q2 FY2025 results
Lifeward's Q2 revenue dipped 14.7% y/y to $5.7M, yet gross margins climbed to 43.9% from 41.1%, buoyed by lower production costs after shifting ReWalk manufacturing in-house and closing the Fremont facility. Operating loss widened to $6.6M from $4.4M, hit by a $2.8M goodwill impairment from a sagging stock price, while net loss hit $6.6M or $(0.58) per share on 11.2M diluted shares—anti-dilution kept it from deeper red. Cash burn eased to $3.9M quarterly, with $5.1M on hand funding ops into Q4 2025, bolstered by $7.8M from equity raises including a June public offering. The AlterG acquisition from August 2023 added $19M cash outlay and potential earnouts, but targets missed, wiping the liability. Nasdaq delisting looms if shares stay below $1.
8-K
Lifeward appoints new CFO
Lifeward Ltd. appointed Almog Adar as Chief Financial Officer effective August 1, 2025, promoting him from Vice President of Finance and Chief Accounting Officer. Adar, 42, brings over four years at the company and prior roles at Infinya Recycling and Delta Galil, now earning $315,000 base salary plus up to 35% performance bonus and 225,000 share options. This internal move bolsters financial leadership amid growth push. Yet risks like funding needs persist.
8-K
Nasdaq bid price deficiency
Lifeward Ltd. received a Nasdaq deficiency notice on August 5, 2025, after its ordinary shares closed below $1.00 for 30 consecutive business days, violating Rule 5550(a)(2). The company has 180 days until February 2, 2026, to regain compliance by sustaining a $1.00 closing price for 10 straight days, with a possible extension if other standards are met. Shares continue trading unaffected. No assurance exists of success. Delisting looms without cure.
BWAY
Brainsway Ltd.
16.80+0.22
DHAI
DIH Holding US, Inc.
2.43-0.31
DYNT
Dynatronics Corp.
0.05+0.00
EKSO
Ekso Bionics Holdings, Inc.
5.25+0.44
EW
Edwards Lifesciences Corporatio
82.69+0.50
INMD
InMode Ltd.
14.92-0.35
LIVN
LivaNova PLC
53.34-0.52
MYO
Myomo Inc.
0.97-0.05
ONWRF
ONWARD MEDICAL NV
4.45-0.97
STME
Stimcell Energetics, Inc.
0.44+0.03